1CN1.5

General

Cell Line

hPSCreg name USFi001-A
Cite as:
USFi001-A (RRID:CVCL_A6XD)
Alternative name(s)
1CN1.5
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
UTSWi001-A-1
(FA1ic)
Donor diseases:
Friedreich Ataxia
UTSWi002-A-1
(FA2ic)
Donor diseases:
Friedreich Ataxia
UTSWi003-A-1
(FA3ic)
Donor's gene variants:
fxn
Donor diseases:
Friedreich Ataxia
UTSWi001-A
(FA1)
Donor diseases:
Friedreich Ataxia
UTSWi002-A
(FA2)
Donor diseases:
Friedreich Ataxia
IGIBi012-A
(FA-hiPSC_001)
Donor diseases:
Friedreich Ataxia
IGIBi013-A
(FA_hiPSC_002)
Donor diseases:
Friedreich Ataxia
IGIBi016-A
(FA-hiPSC_005)
Donor diseases:
Friedreich Ataxia
UTSWi003-A
(FA3)
Donor's gene variants:
fxn
Donor diseases:
Friedreich Ataxia
UTSWi001-A-2
(FA1-N)
Donor diseases:
Friedreich Ataxia
UTSWi001-A-3
(FA1ic-N)
Donor diseases:
Friedreich Ataxia
UTSWi002-A-2
(FA2-N)
Donor diseases:
Friedreich Ataxia
UTSWi002-A-3
(FA2ic-N)
Donor diseases:
Friedreich Ataxia
UTSWi003-A-2
(FA3-N)
Donor's gene variants:
fxn
Donor diseases:
Friedreich Ataxia
UTSWi003-A-3
(FA3ic-N)
Donor's gene variants:
fxn
Donor diseases:
Friedreich Ataxia
INSRMi019-A
(PC129K8)
Donor diseases:
myofibrillar myopathy 1
INSRMi020-A
(PC130k2c)
Donor diseases:
myofibrillar myopathy 1
CUIMCi005-A
(BB#2, BB9068#2)
Donor diseases:
Stargardt Disease
FJMUUHi001-A
Donor's gene variants:
PARK7
Donor diseases:
Parkinson's disease 7
SCTCi014-A
(IPS17-00056)
Donor diseases:
Age-Related Macular Degeneration
BIHi002-A
Donor's gene variants:
CLCN7, CLCN7
Donor diseases:
autosomal recessive osteopetrosis 4
SCTCi012-A
(IPS19-00027)
Donor diseases:
age-related macular degeneration
IGIBi001-A
(SCP28)
Donor diseases:
Sickle cell anemia
SCTCi013-A
(IPS19-00053)
Donor diseases:
age-related macular degeneration
INSRMi012-C
(PC173T19)
Donor diseases:
myofibrillar myopathy 1
INSRMi013-A
(PC179c1)
Donor diseases:
myofibrillar myopathy 1
CMCi002-A
(CMC-GIT-001)
Donor diseases:
Gitelman Syndrome
SIAISi007-A
(ZSJ)
Donor diseases:
Alzheimer's Disease
PNUSCRi001-A
(GBA PD iPSC7)
Donor's gene variants:
GBA
Donor diseases:
Parkinson Disease
PNUSCRi002-A
(GBA PD iPSC9)
Donor's gene variants:
GBA
Donor diseases:
Parkinson Disease
ICGi042-A
(PD12-4Lm)
Donor's gene variants:
LRRK2, PINK1
Donor diseases:
Parkinson Disease
ICGi042-B
(PD12-5Lm)
Donor's gene variants:
LRRK2, PINK1
Donor diseases:
Parkinson Disease
ICGi042-C
(PD12-6Lm)
Donor's gene variants:
LRRK2, PINK1
Donor diseases:
Parkinson Disease
BCHNi001-A
(BCHi001-A)
Donor diseases:
Bardet-Biedl Syndrome
LZUSHi001-A
(ips98)
Donor diseases:
Generalized Epilepsy
ICGi023-A
(PD45-6-1Lm)
Donor's gene variants:
LRRK2
Donor diseases:
Parkinson Disease
Last update 15th April 2022
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator University of South Florida (USF)
Derivation country United States

External Databases

BioSamples SAMEA8192624
Cellosaurus CVCL_A6XD
Wikidata Q107117353

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Synonyms
  • Friedreich's Ataxia
  • Friedreich Ataxia
  • Friedreich ataxia

External Databases (Donor)

BioSamples SAMEA8192625

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. anonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent the derivation of pluripotent stem cells? No
Does consent prevent the DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? University of South Florida IRB
Approval number Pro00033948
Do you have obligations to third parties in regard to the use of the cell line? No
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? Thermo Fisher

hIPSC Derivation

General

Source cell type
A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.
Synonyms
  • PERIPHERAL BLOOD MONONUCLEAR CELL
  • Peripheral Blood Mononuclear Cell
  • PBMC
Source cell origin
A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.
Synonyms
  • Reticuloendothelial System, Blood
  • Peripheral Blood
  • peripheral blood
  • blood
  • Blood
  • Whole Blood
  • BLOOD
  • portion of blood
  • vertebrate blood
show more synonyms

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Is reprogramming vector detectable?
No
Methods used
PCR

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Surface coating Matrigel/Geltrex
Medium Other medium:
Base medium: mTeSR™ Plus
Main protein source:
Serum concentration: %

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
SOX2
Yes
TRA 1-60
Yes
SSEA-4
Yes
POU5F1 (OCT-4)
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
SOX17
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
PECAM1
Yes
CDH5
Unknown
Morphology
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
NESTIN
Unknown
PAX6
Unknown
Morphology

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
Normal, 46 XY
Passage number: p28
Karyotyping method: KaryoStat™ assay (Thermo Fisher)

Other Genotyping (Cell Line)